Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study
M Johnsson, YT Stenberg, HH Farman… - Multiple Sclerosis …, 2024 - journals.sagepub.com
Background: Serum neurofilament light (sNfL) reflects neuroaxonal damage and is now
used as an outcome in treatment trials of relapsing-remitting multiple sclerosis (RRMS) …
used as an outcome in treatment trials of relapsing-remitting multiple sclerosis (RRMS) …
Neurofilament in clinical practice: Is the multiple sclerosis community ready?
M Moccia, D Terracciano… - Multiple Sclerosis …, 2024 - journals.sagepub.com
Multiple Sclerosis Journal 00 (0) 2 journals. sagepub. com/home/msj baseline z-score
performed better than absolute NfL values in identifying cases with clinical/MRI activity …
performed better than absolute NfL values in identifying cases with clinical/MRI activity …
Does serum neurofilament light chain measurement influence therapeutic decisions in multiple sclerosis?
G Saposnik, E Monreal, N Medrano… - Multiple Sclerosis and …, 2024 - Elsevier
Background The assessment of serum neurofilament light chain (sNfL) concentration in
multiple sclerosis (MS) is a useful tool for predicting clinical outcomes and assessing …
multiple sclerosis (MS) is a useful tool for predicting clinical outcomes and assessing …
Using serum neurofilament-light in clinical practice: Growing enthusiasm that may need bridling
J Lycke, RJ Fox - Multiple Sclerosis Journal, 2024 - journals.sagepub.com
Multiple Sclerosis Journal 00 (0) 2 journals. sagepub. com/home/msj marked certainty of the
clinicians surveyed in the van Lierop's study, and the delayed rise in sNFL suggests that …
clinicians surveyed in the van Lierop's study, and the delayed rise in sNFL suggests that …
Real-World Study of Serum Neurofilament Light Chain Levels in Ocrelizumab-Treated People with Relapsing Multiple Sclerosis
FJ Barrero Hernández, A Romero Villarrubia… - Journal of Personalized …, 2024 - mdpi.com
Serum neurofilament light chain (sNfL) levels have been proposed as a biomarker of the
clinical activity, disability progression, and response to treatment of people with multiple …
clinical activity, disability progression, and response to treatment of people with multiple …
[HTML][HTML] Clinical utility of the Lumipulse™ immunoassay for plasma neurofilament light chain in multiple sclerosis
V Nicolella, M Fiorenza, I Monteiro, F Novarella… - Journal of the …, 2024 - Elsevier
Objective Blood neurofilament light chain (NfL) is robustly associated with disease
worsening in multiple sclerosis (MS), though potentially affected by concomitant factors also …
worsening in multiple sclerosis (MS), though potentially affected by concomitant factors also …